These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15269742)

  • 21. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants and children's depression.
    Diller L
    Am J Psychiatry; 2005 Jun; 162(6):1226-7. PubMed ID: 15930080
    [No Abstract]   [Full Text] [Related]  

  • 23. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 27. Calls for full disclosure of clinical trials.
    Frantz S
    Nat Rev Drug Discov; 2004 Aug; 3(8):635-6. PubMed ID: 15317144
    [No Abstract]   [Full Text] [Related]  

  • 28. Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions.
    Healy D
    West J Med; 2001 Dec; 175(6):364. PubMed ID: 11733415
    [No Abstract]   [Full Text] [Related]  

  • 29. Are SSRIs safe for children?
    Med Lett Drugs Ther; 2003 Jul; 45(1160):53-4. PubMed ID: 12840712
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants and pediatric depression--the risk of doing nothing.
    Brent DA
    N Engl J Med; 2004 Oct; 351(16):1598-601. PubMed ID: 15483276
    [No Abstract]   [Full Text] [Related]  

  • 32. [Unfortunate title?].
    Waern M; Agren H; Hägglöf B; Lundin B
    Lakartidningen; 2004 Jun; 101(26-27):2292. PubMed ID: 15281636
    [No Abstract]   [Full Text] [Related]  

  • 33. Industry-sponsored ghostwriting in clinical trial reporting: a case study.
    McHenry LB; Jureidini JN
    Account Res; 2008; 15(3):152-67. PubMed ID: 18792536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paroxetine-induced mania.
    Oldroyd J
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):721-2. PubMed ID: 9183122
    [No Abstract]   [Full Text] [Related]  

  • 35. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 36. The whole truth: drug companies must tell us all they know about the medicines we take.
    New Sci; 2004 May 1-7; 182(2445):3. PubMed ID: 15278970
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug treatment of depression in children and adolescents].
    Grøholt B
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants in the postpartum period: additional considerations.
    Burbeck R; Pilling S; Tomson D; McDonald L
    Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193
    [No Abstract]   [Full Text] [Related]  

  • 39. [I don't see "dramatic increase"].
    Högberg G
    Lakartidningen; 2009 Feb 18-24; 106(8):530. PubMed ID: 19353798
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.